medigraphic.com
ISSN 1561-302X (Print)

2022, Number 4

<< Back Next >>

Rev cubana med 2022; 61 (4)

F-wave, sensory potential and nociceptive response in a rat model of streptozotocin-induced diabetic neuropathy

Romero-Hernández G, Pérez-Saad H, Fernández-Mayola M, Risco-Acevedo D, Garcia-del-Barco D

Language: Spanish
References: 14
Page: 1-10
PDF size: 605.12 Kb.


ABSTRACT

Introduction: F-wave, sensory potentials and nociceptive response to painful stimulus are neurophysiological tests used to address the neuropathic condition in experimental models performed in laboratory animals.
Objective: To demonstrate the effectiveness of a new dosing schedule in a rat model of streptozotocin-induced diabetic neuropathy.
Methods: Streptozotocin was administered to adult Wistar rats at doses of 30 mg/kg per day on alternate days (Monday, Wednesday and Friday) for one week. Glycemic levels and body weight were measured before streptozotocin treatment and weekly throughout the experimental period (6 weeks). The F wave was recorded in the foot muscles with ankle stimulation. The sensory potential of the caudal nerves was recorded. The reaction time to a thermal nociceptive stimulus was examined in the hot plate test.
Results: In animals treated with streptozotocin sustained levels of hyperglycemia and progressive reduction of body weight revealed diabetic neuropathic condition, also F-wave conformation and its parameters (amplitude, integral index and persistence) were severely reduced, as well as velocity conduction for sensory potential (p˂0.05), reaction time increased significantly (p˂ 0.05).
Conclusions: Neurophysiological tests were effective in demonstrating that the dosing schedule used is capable of developing peripheral neuropathy over a six-week period. The changes in the F wave were particularly relevant and suggest that, in parallel with peripheral sensory transmission, evidenced by sensory potential and reaction time, there is neuropathic involvement of the central and/or proximal portions of the motor fibers.


REFERENCES

  1. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553-79.

  2. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, et al. Single dose streptozotocin- induced diabetes: considerations for study design in islet transplantation models. Lab Anim. 2011;45:131-40.

  3. Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2015;70:5.47.1-5.47.20. DOI: https://doi:10.1002/0471141755.ph0547s70.

  4. Jolivalt CG, Frizzi KE, Guernsey L, Marquez A, Ochoa J, Rodriguez M, et al. Peripheral neuropathy in mouse models of diabetes. Curr Protoc Mouse Biol. 2016;6:223-55. DOI: https://doi:10.1002/cpmo.11

  5. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216-26.

  6. Horn M, Baumann R, Pereira JA, Sidiropoulos PNM, Somandin C, Welzl H, et al. Myelin is dependent on the Charcot-Marie-Tooth type 4H disease culprit protein Frabin/FGD4 in Schwann cells. Brain. 2012;135:3567-83.

  7. Fisher MA. F-waves-physiology and clinical uses. Sci World J 2007;7:144-60.

  8. Pérez-Saad H, Subiros N, Berlanga J, Aldana L, García del Barco D. Neuroprotective effect of epidermal growth factor in experimental acrylamide neuropathy: an electrophysiological approach. J Peripher Nerv Syst. 2017;22:106-11. DOI: https://doi: 10.1111/jns.12214

  9. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 1967;126:201-5.

  10. Mishra D, Ghosh G, Kumar S, Panda PK. An experimental study of analgesic activity of selective COX-2 inhibitor with conventional NSAIDs. Asian J Pharm Clin Res 2010;4:78-81.

  11. Fisher MA. F-waves in diabetes mellitus: Answers and questions. Muscle Nerve 2014;49:783-5.

  12. Cameron NE, Jack AM, Cotter MA. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic Biol Med 2001;31:125-35.

  13. Schlosser MJ, Kapeghian JC, Verlangieri AJ. Effects of streptozotocin in the male guinea pig: a potential animal model for studying diabetes. Life Sci 1984;35:649-55.

  14. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50:537-46.




2020     |     www.medigraphic.com